Earnings History Data for Cyclacel Pharmaceuticals, Inc. (CYCC) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Cyclacel Pharmaceuticals, Inc.

CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
13-11-2023 PM CYCC Cyclacel Pharmaceuticals, Inc. 7.33 -0.49 -0.38 -0.42 Cyclacel Pharmaceuticals GAAP EPS of -$0.49 misses by $0.13, revenue of $0.02M
[11/14/2023 9:59 AM]
0.3251 -0.20 
(-37.54%)
0.51 -0.01 
(-2.38%)
0.28 - 1.23 515,856 90,000 235
09-08-2023 AH CYCC Cyclacel Pharmaceuticals, Inc. 7.42 -0.44 -0.54 -0.46 Cyclacel Pharmaceuticals GAAP EPS of -$0.44 beats by $0.06, revenue of $0.37M
[8/9/2023 4:49 PM]
0.5570 0.0 
(0.91%)
0.60 0.05 
(8.70%)
0.50 - 2.41 74,907 50,000 3,290
11-05-2023 AH 4:05 PM ET
(May 11)
CYCC Cyclacel Pharmaceuticals, Inc. 7.12 -0.47 -0.68 -0.42 Cyclacel Pharmaceuticals GAAP EPS of -$0.47 beats by $0.19
[5/11/2023 4:49 PM]
0.5504 -0.01 
(-1.24%)
0.58 0.02 
(2.98%)
0.50 - 2.41 30,070 70,000 575
06-03-2023 AH 4:05 PM ET
(Mar 6)
CYCC Cyclacel Pharmaceuticals 10.00 -0.60 -0.53 0.00 Cyclacel Pharmaceuticals GAAP EPS of -$0.60 misses by $0.12
[3/6/2023 4:20 PM]
0.7047 -0.04 
(-5.85%)
0.71 -0.04 
(-4.89%)
0.53 - 3.55 71,949 70,000 3,215
09-11-2022 AH 4:05 PM ET
(Nov 9)
CYCC Cyclacel Pharmaceuticals, Inc. 15.80 -0.42 -0.55 -0.54 Cyclacel Pharmaceuticals GAAP EPS of -$0.42 beats by $0.14
[11/9/2022 4:21 PM]
1.16 -0.02 
(-1.69%)
0.0 0.0 
(0.00%)
1.01 - 5.59 67,637 110,000 0
10-08-2022 AH 4:05 PM ET
(Aug 10)
CYCC Cyclacel Pharmaceuticals, Inc. 13.19 -0.46 -0.67 -0.56 Cyclacel Pharmaceuticals GAAP EPS of -$0.46 beats by $0.08, revenue of $0M
[8/10/2022 5:53 PM]
1.70 0.37 
(27.82%)
1.49 0.16 
(12.03%)
1.01 - 6.10 7,604,024 850,000 1,974,787
11-05-2022 AH 4:05 PM ET
(May 11)
CYCC Cyclacel Pharmaceuticals, Inc. 14.69 -0.42 -0.67 -0.50 Cyclacel Pharmaceuticals GAAP EPS of -$0.42 beats by $0.27
[5/11/2022 4:16 PM]
1.38 0.06 
(4.70%)
1.32 0.0 
(0.00%)
1.29 - 7.95 45,006 60,000 550
28-03-2022 AH 4:05 PM ET
(Mar 28)
CYCC Cyclacel Pharmaceuticals, Inc. 31.62 -0.54 -0.71 -1.34 Cyclacel Pharmaceuticals GAAP EPS of -$1.34
[3/28/2022 4:34 PM]
3.24 0.09 
(2.86%)
3.30 0.15 
(4.76%)
2.63 - 7.95 22,118 30,000 1,000
10-11-2021 AH 4:05 PM ET
(Nov 10)
CYCC Cyclacel Pharmaceuticals, Inc. 45.80 -0.54 -0.70 -0.47 Cyclacel Pharmaceuticals EPS beats by $0.23
[11/10/2021 4:41 PM]
4.99 -0.11 
(-2.16%)
5.02 -0.08 
(-1.57%)
3.34 - 11.42 76,544 60,000 415
11-08-2021 AH 4:05 PM ET
(Aug 11)
CYCC Cyclacel Pharmaceuticals, Inc. 47.93 -0.56 -0.47 -0.58 Cyclacel Pharmaceuticals EPS misses by $0.07
[8/11/2021 4:23 PM]
5.05 -0.17 
(-3.26%)
5.20 -0.02 
(-0.38%)
3.12 - 11.42 66,748 60,000 180
12-05-2021 AH 4:05 PM ET
(May 12)
CYCC Cyclacel Pharmaceuticals, Inc. 61.04 -0.50 -0.45 -1.48 Cyclacel Pharmaceuticals EPS misses by $0.99
[5/12/2021 4:28 PM]
6.65 0.28 
(4.40%)
6.90 0.53 
(8.32%)
3.12 - 11.42 114,023 220,000 1,009
25-02-2021 AH 4:05 PM ET
(Feb 25)
CYCC Cyclacel Pharmaceuticals, Inc. 35.31 -1.34 -0.51 -2.80 Cyclacel Pharmaceuticals EPS misses by $2.21
[2/25/2021 5:04 PM]
6.91 -0.09 
(-1.29%)
6.95 -0.05 
(-0.71%)
3.12 - 19.25 383,310 653,643 4,829
11-11-2020 AH 4:05 PM ET
(Nov 11)
CYCC Cyclacel Pharmaceuticals, Inc. 16.20 -0.47 -0.49 -2.20 Cyclacel Pharmaceuticals EPS misses by $1.74
[11/11/2020 4:14 PM]
3.46 -0.05 
(-1.42%)
3.50 -0.01 
(-0.28%)
3.12 - 19.60 43,871 47,839 419
12-08-2020 AH 4:05 PM ET
(Aug 12)
CYCC Cyclacel Pharmaceuticals, Inc. 23.86 -0.58 -0.47 -3.20 Cyclacel Pharmaceuticals EPS misses by $1.66
[8/12/2020 4:19 PM]
4.27 -0.29 
(-6.36%)
4.25 -0.31 
(-6.80%)
3.85 - 19.60 287,139 488,873 7,697
12-05-2020 AH 4:05 PM ET
(May 12)
CYCC Cyclacel Pharmaceuticals, Inc. 11.41 -1.48 -2.80 3.00 Cyclacel Pharmaceuticals EPS beats by $0.13
[5/12/2020 4:09 PM]
4.22 0.09 
(2.18%)
4.18 -0.04 
(-0.95%)
3.85 - 20.40 5,562,360 632,426 20,486